SARX is a specialist medical practice in Roeselare. Private Limited, started on 17 March 2011, 1 establishment.

What is the address of SARX?

The registered office of SARX is located at Zwaanhof 1, 8800 Roeselare.

Is SARX still active?

Yes. According to the CBE (29 October 2026) SARX is active, legal situation “Normale toestand”, started on 17 March 2011.

Is SARX registered on Peppol?

Yes, SARX is registered on the Peppol network with ID 0208:0834620959.

What is the enterprise number of SARX?

The enterprise number of SARX is BE0834620959.

When was SARX founded?

SARX was founded on 17 March 2011.

Who are the directors of SARX?

According to the 2025 annual accounts, the directors of SARX are: Sofie Allewaert.

Is SARX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 March 2011; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did SARX make in 2025?

SARX posted a profit after taxes of € 352,332 in financial year 2025.

What is the revenue of SARX?

As a small company, SARX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 480,938.

SARX (Private Limited) - Roeselare - BE0834620959

Dossier SARX, printed on 29 October 2026 from databakkes.be/en/0834620959/sarx. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SARX from Roeselare, company number BE0834620959, closed financial year 2025 with a result of € 352,332 after tax. For that financial year SARX recorded a gross margin of € 480,938 and equity of € 208,973. Compared with financial year 2024, the result moved from € 320,868 to € 352,332. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 208,973

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 352,332

▲ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 280,138

▼ 23% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 352,000 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 40,445

▼ 24% vs 2024

Of which on lease € 40,445.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 42,516

▼ 22% vs 2024

€ 12,197 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 1,597

▼ 36% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,685

▼ 92% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 442,128 Gross margin 2022: € 442,128 First fiscal year in the series	€ 472,082 Gross margin 2023: € 472,082 ▲ 7% vs 2022 (€ 442,128) Favourable step	€ 459,117 Gross margin 2024: € 459,117 ▼ 3% vs 2023 (€ 472,082) Unfavourable step	€ 480,938 Gross margin 2025: € 480,938 ▲ 5% vs 2024 (€ 459,117) Favourable step	▲ 5%
Profit after taxes	€ 333,075 Profit after taxes 2022: € 333,075 First fiscal year in the series	€ 355,870 Profit after taxes 2023: € 355,870 ▲ 7% vs 2022 (€ 333,075) Favourable step	€ 320,868 Profit after taxes 2024: € 320,868 ▼ 10% vs 2023 (€ 355,870) Unfavourable step	€ 352,332 Profit after taxes 2025: € 352,332 ▲ 10% vs 2024 (€ 320,868) Favourable step	▲ 10%
Equity	€ 55,800 Equity 2022: € 55,800 First fiscal year in the series	€ 55,800 Equity 2023: € 55,800 Unchanged (€ 55,800) Unchanged	€ 208,641 Equity 2024: € 208,641 ▲ 274% vs 2023 (€ 55,800) Favourable step	€ 208,973 Equity 2025: € 208,973 Unchanged (€ 208,641) Favourable step
Total debts	€ 235,596 Total debts 2022: € 235,596 First fiscal year in the series	€ 390,143 Total debts 2023: € 390,143 ▲ 66% vs 2022 (€ 235,596) Unfavourable step	€ 356,998 Total debts 2024: € 356,998 ▼ 8% vs 2023 (€ 390,143) Favourable step	€ 383,565 Total debts 2025: € 383,565 ▲ 7% vs 2024 (€ 356,998) Unfavourable step	▲ 7%
Cash	€ 196,556 Cash 2022: € 196,556 First fiscal year in the series	€ 326,564 Cash 2023: € 326,564 ▲ 66% vs 2022 (€ 196,556) Favourable step	€ 363,773 Cash 2024: € 363,773 ▲ 11% vs 2023 (€ 326,564) Favourable step	€ 280,138 Cash 2025: € 280,138 ▼ 23% vs 2024 (€ 363,773) Unfavourable step	▼ 23%
Retained profit	€ 0 Retained profit 2022: € 0 First fiscal year in the series	€ 0 Retained profit 2023: € 0 Unchanged (€ 0) Unchanged	€ 152,841 Retained profit 2024: € 152,841 Unchanged (€ 0) Favourable step	€ 153,173 Retained profit 2025: € 153,173 Unchanged (€ 152,841) Favourable step
Dividend	€ 386,475 Dividend 2022: € 386,475 First fiscal year in the series	€ 355,870 Dividend 2023: € 355,870 ▼ 8% vs 2022 (€ 386,475) Unchanged	€ 168,027 Dividend 2024: € 168,027 ▼ 53% vs 2023 (€ 355,870) Unchanged	€ 352,000 Dividend 2025: € 352,000 ▲ 109% vs 2024 (€ 168,027) Unchanged	▲ 109%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 54,339 Bank debt 2024: € 54,339 Unchanged (€ 0) Unfavourable step	€ 42,516 Bank debt 2025: € 42,516 ▼ 22% vs 2024 (€ 54,339) Favourable step	▼ 22%
Balance sheet total	€ 291,396 Balance sheet total 2022: € 291,396 First fiscal year in the series	€ 445,943 Balance sheet total 2023: € 445,943 ▲ 53% vs 2022 (€ 291,396) Unchanged	€ 565,638 Balance sheet total 2024: € 565,638 ▲ 27% vs 2023 (€ 445,943) Unchanged	€ 592,538 Balance sheet total 2025: € 592,538 ▲ 5% vs 2024 (€ 565,638) Unchanged	▲ 5%

Key figures of SARX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SARX?

What happened at SARX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 352,332 (▲ 10% vs 2024). filed late Source: NBB ↗
Mar 17, 2011 New establishment in Roeselare. KBO
Mar 17, 2011 Start of the company according to the CBE. KBO
2011 Sofie Allewaert became a director. NBB

In short

From € 333,075 profit in 2022 to € 352,332 profit in 2025.

Paid € 460,927 in corporate taxes since 2022.

Best year ever: 2023, with € 355,870 profit.

Paid out € 1.3 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Sofie Allewaert

SARX

Yperad

Behind SARX is Sofie Allewaert. Sofie Allewaert is also behind Yperad.

Directors

According to the 2025 annual accounts

Sofie Allewaert

Director

Also active at: Yperad

since 2011

Establishments

Establishment units

Physical locations of this company

Registered office

Zwaanhof 1

8800 Roeselare

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0834.620.959

VAT number

BE 0834.620.959

Registered office

Zwaanhof 1, 8800 Roeselare

Names & denominations

SARX

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

17 March 2011

Peppol

Active · Active since 4 Feb 2026

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

SARX

Financials

What happened to SARX?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions